MIRA Pharmaceuticals
MIRAPhase 1With small changes, MIRA’s technology focuses on big effects that have the potential to redefine therapeutic outcomes, opening up new markets for indications and patients.
Market Cap
$38.5M
Focus
Small Molecules
MIRA · Stock Price
USD 0.926.50 (-87.60%)
Historical price data
About
With small changes, MIRA’s technology focuses on big effects that have the potential to redefine therapeutic outcomes, opening up new markets for indications and patients.
Pipeline Snapshot
11 drug in pipeline
| Drug | Indication | Stage | Watch |
|---|---|---|---|
| Toujeo | Diabetes Mellitus, Type 2 | Approved |
Funding History
2Total raised: $6M
IPO$6MUndisclosedAug 15, 2023
SeedUndisclosedUndisclosedJun 15, 2021
Company Info
TypePublic
LocationUnited States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile